Oxford-AstraZeneca Covid-19 Vaccine Startup in Conflict With University Ahead of Planned IPO

Oxford-AstraZeneca Covid-19 Vaccine Startup in Conflict With University Ahead of Planned IPO

A startup behind the Covid-19 vaccine developed by the University of Oxford and AstraZeneca is planning an IPO that backers hope will be the biggest market debut of an Oxford spinoff in years. One hurdle: the university itself.